Edition:
United States

Grifols SA (GRFS.OQ)

GRFS.OQ on NASDAQ Stock Exchange Global Select Market

19.73USD
17 Oct 2018
Change (% chg)

$-0.04 (-0.20%)
Prev Close
$19.77
Open
$19.83
Day's High
$19.90
Day's Low
$19.50
Volume
164,356
Avg. Vol
244,231
52-wk High
$25.17
52-wk Low
$18.70

Latest Key Developments (Source: Significant Developments)

Grifols FY Net Profit Up At 662.7 Mln Euros
Wednesday, 28 Feb 2018 02:27am EST 

Feb 28 (Reuters) - Grifols ::FY NET SALES 4.32 BILLION EUROS VERSUS 4.05 BILLION EUROS YEAR AGO.FY NET PROFIT 662.7 MILLION EUROS VERSUS 545.5 MILLION EUROS YEAR AGO.  Full Article

Grifols Receives FDA Approval For New Formulation Of Its Rabies Virus Treatment
Tuesday, 6 Feb 2018 09:45am EST 

Feb 6 (Reuters) - Grifols SA ::GRIFOLS HYPERRAB® (RABIES IMMUNE GLOBULIN HUMAN) 300 IU/ML RECEIVES FDA APPROVAL TO TREAT PATIENTS EXPOSED TO RABIES VIRUS INFECTION.  Full Article

Grifols Buys 51 Pct Of Medkeeper
Friday, 26 Jan 2018 02:28am EST 

Jan 26 (Reuters) - GRIFOLS SA ::BUYS 51 PERCENT SHARE CAPITAL IN MEDKEEPER.SAYS PURCHASE RESULT OF $98 MLN CAPITAL INCREASE IN MEDKEEPER.NEGOTIATED CALL OPTION TO ACQUIRE REMAINING 49 PERCENT INTEREST EXERCISABLE DURING 3 YEAR PERIOD.  Full Article

Grifols says FDA approves genetic test and EMA biological sealant
Friday, 17 Nov 2017 11:32am EST 

Nov 17 (Reuters) - GRIFOLS SA ::GETS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS NEW GENETIC TEST TO DETECT ALPHA-1 ANTITRYPSIN DEFICIENCY‍​.THE EUROPEAN MEDICINES AGENCY (EMA) APPROVES NEW PRODUCT, BIOLOGICAL SEALANT, TO USE IN SURGICAL OPERATIONS IN ADULTS.‍​.  Full Article

Grifols gets approval from US FDA for new product
Monday, 6 Nov 2017 02:25am EST 

Nov 6 (Reuters) - GRIFOLS SA ::EARNS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR NEW PRODUCT FIBRIN SEALANT (HUMAN) COMPOSED OF TWO PLASMA PROTEINS AND INDICATED FOR SURGICAL USE IN ADULTS.‍​.  Full Article

Grifols 9-month net profit up 6.3 pct at 431.8 mln euros YoY
Thursday, 2 Nov 2017 03:22am EDT 

Nov 2 (Reuters) - GRIFOLS SA ::9-MONTH NET PROFIT 431.8 MILLION EUROS VERSUS 406.1 MILLION EUROS YEAR AGO.9-MONTH NET SALES 3.25 BILLION EUROS VERSUS 2.95 BILLION EUROS YEAR AGO.9-MONTH EBITDA 960.9 MILLION EUROS VERSUS 842.9 MILLION EUROS YEAR AGO.  Full Article

Grifols approves interim dividend of 0.18 eur/shr
Monday, 30 Oct 2017 03:18am EDT 

Oct 30 (Reuters) - GRIFOLS SA ::APPROVES INTERIM DIVIDEND OF 0.18 EURO PER SHARE PAYABLE DECEMBER 5‍​.  Full Article

Grifols gets FDA approval for Prolastin-C
Friday, 22 Sep 2017 02:27am EDT 

Sept 22 (Reuters) - GRIFOLS SA ::SAYS GETS APPROVAL FROM FDA (US FOOD AND DRUG ADMINISTRATION) FOR PROLASTIN-C LIQUID AS A REPLACEMENT THERAPY‍​ TO TREAT RARE GENETIC DISORDER.SAYS COMMERCIAL LAUNCH OF LIQUID FORMULATION PROLASTIN-C IS SCHEDULED FOR 2018.THE APPROVAL PROCESS FOR THE PRODUCT ALSO COMMENCED IN EUROPE.  Full Article

Grifols H1 EBITDA up 16.4 pct versus last year
Friday, 28 Jul 2017 02:32am EDT 

July 28 (Reuters) - GRIFOLS SA ::H1 NET PROFIT 277.9 MILLION EUROS VERSUS 264.4 MILLION EUROS YEAR AGO.H1 EBITDA 644.4 MILLION EUROS VERSUS 553.6 MILLION EUROS YEAR AGO.H1 NET REVENUE 2.19 BILLION EUROS VERSUS 1.95 BILLION EUROS YEAR AGO.H1 NET INVESTMENT IN R+D UP 19 PERCENT AT 129.3 MILLION EUROS.  Full Article

Grifols reaches 90 pct stake in Kiro Grifols
Tuesday, 25 Jul 2017 02:30am EDT 

July 25 (Reuters) - GRIFOLS ::SAYS BUYS ADDITIONAL 40 PERCENT OF KIRO GRIFOLS SL FOR 12.8 MILLION EUROS‍​.SAYS AFTER THE TRANSACTION REACHES 90 PERCENT STAKE IN KIRO GRIFOLS.THE REMAINING 10 PERCENT OF KIRO GRIFOLS WILL CONTINUE TO BE HELD BY SOCIOS FUNDADORES KIRO SL.  Full Article

Spanish stocks - Factors to watch on Thursday

The following Spanish stocks may be affected by newspaper reports and other factors on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: